Loading stock data…
MD
$23.43-0.08 (-0.34%)
Market OpenUpdated 3:45 PM EDT
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Pediatrix Medical Group, Inc. in the Healthcare sector is trading at $23.43. The stock is currently near its 52-week high of $24.99, remaining 18.9% above its 200-day moving average. Technical signals show neutral RSI of 54 and bearish MACD signal, explaining why MD maintains its current momentum and trend strength. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 54) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$23.43
Potential Upside
72.7%
Whystock Fair Value$40.46
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus6 analysts
Buy
Mean target$22.67-3.3%
Range$19.00 – $27.00
Fundamentals
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications wi...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.92B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
11.89
Beta
Defensive asset. Lower volatility than the S&P 500.
0.72
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
12.69%
Volume
Today's trading volume
528,035
Recent News
Pediatrix Medical Group Q1 Earnings Call Highlights
Pediatrix Medical Group (NYSE:MD) reaffirmed its full-year 2026 adjusted EBITDA outlook after reporting what management described as a strong first quarter, supported by higher pricing, improved collections and continued strength in payer mix despite modest volume declines across its service lines.
Pediatrix Medical Group, Inc. Just Recorded A 10% EPS Beat: Here's What Analysts Are Forecasting Next
As you might know, Pediatrix Medical Group, Inc. ( NYSE:MD ) just kicked off its latest quarterly results with some...
Pediatrix Medical Q1 Earnings Beat Estimates on Same-Unit Strength
Pediatrix Medical Group tops Q1 estimates as stronger reimbursements and same-unit gains lift results despite lower patient volumes.
Pediatrix Medical Group, Inc. Q1 2026 Earnings Call Summary
Moby summary of Pediatrix Medical Group, Inc.'s Q1 2026 earnings call
Pediatrix Medical Group (MD) Q1 Earnings and Revenues Surpass Estimates
Pediatrix Medical Group (MD) delivered earnings and revenue surprises of +19.73% and +1.97%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?